Venture Capital Investors

108 BioCapital

108 BioCapital provides venture capital investment to companies focused on high-impact, technology-driven solutions.

Venture Investor Overview

Contact Information

Background Information

Overview

At 108 BioCapital, we are dedicated to advancing the frontiers of medical innovation. Our mission is to invest in transformative healthcare solutions that address urgent unmet medical needs, improve patient outcomes, and deliver sustained value to our investors. The US healthcare and medtech sectors present an extraordinary growth opportunity, with healthcare spending projected to reach 20% of GDP by 2032. Advances in diagnostics, therapeutic devices, and personalized medicine are reshaping the industry. We seek to partner with visionary entrepreneurs and management teams, leveraging our expertise and network to accelerate growth and maximize impact.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/22/2026

Transaction History

Our records indicate that 108 BioCapital invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Sasha Bakhru

        

General Partner

Shom Jagtiani

        

General Partner

Shahryar Oveissi

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

108 BioCapital has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

10100 Fund | 10D

Share this article

About Our VC Firm Database

The venture capital investor data above is provided by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary